CN
EN
Home
Technology
Products
Recombinant Human Serum Albumin
Reagent Grade (Recombinant Human Serum Albumin, HyWill)
Excipient Grade (Recombinant Human Serum Albumin)
Cell Culture Grade (Recombinant Human Serum Albumin)
Recombinant Growth factors
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Insulin-like Growth Factor-1 LR3 (rhIGF-1 LR3)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Proteins for Cosmetics Ingredients
Recombinant Human basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Other Recombinant Proteins
Recombinant Human Transferrin (HyCreat, OsrhTF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Recombinant Human α-1 Antitrypsin (OsrhAAT)
Services
Recombinant Protein Expression
Purification Process Development
Detection Methodology Service
Company
About us
Development
R&D Team
Careers
News
Events
Contact
FAQ
Company info
Feedback
Privacy policy
Home
Technology
Products
Recombinant Human Serum Albumin
Reagent Grade (Recombinant Human Serum Albumin, HyWill)
Excipient Grade (Recombinant Human Serum Albumin)
Cell Culture Grade (Recombinant Human Serum Albumin)
Recombinant Growth factors
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Insulin-like Growth Factor-1 LR3 (rhIGF-1 LR3)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Proteins for Cosmetics Ingredients
Recombinant Human basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Other Recombinant Proteins
Recombinant Human Transferrin (HyCreat, OsrhTF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Recombinant Human α-1 Antitrypsin (OsrhAAT)
Services
Recombinant Protein Expression
Purification Process Development
Detection Methodology Service
Company
About us
Development
R&D Team
Careers
News
Events
Contact
FAQ
Company info
Feedback
Privacy policy
About us
Development
R&D Team
Careers
News
Events
Healthgen Biotech Wonderful memories at KSSCR International Symposium 2019
On September 26-28, 2019, the 3-days KSSCR International Symposium 2019 was successfully ended in Grand Hilton Seoul, South Korea. 2019 ISSCR/KSSCR International Symposium is a joint meeting of the Korean Society for Stem Cell Research (KSSCR) and th...
Posted by Site editor
|
2019-10-08
LearnMore
Recombinant Human Serum Albumin(OsrHSA) From Rice Was Approved By USA FDA For Clinical Study
On August 10, 2019, Wuhan Healthgen Biotechnology Co., Ltd. received approval from the FDA of the United States for clinical trials on OsrHSA injection that was produced from rice expression platform. This is the first blood product from China which was approved for clinical tr...
Posted by Site editor
|
2019-08-10
LearnMore
Healthgen Biotech will attend the World Advanced Therapies & Regenerative Medicine Congress 2019 in London, UK
Date: 5/15/2019 - 5/17/2019 Venue: Business Design Centre Address: Business Design Centre Ltd,, 52 Upper St, London N1 0QH Booth No: #6 The World Advanced Therapies&Regenerative Medicine Congress is Europe’s most important advance...
Posted by Site editor
|
2019-05-04
LearnMore
Recombinant Human Serum Albumin(OsrHSA) Derived From Oryza Sativa Has Been Approved By CFDA For The Clinical Trial In China
OsrHSA, a recombinant human serum albumin derived from transgenic rice seeds has gained the approval of the clinical trial from Chinese Food and Drug Administration (CFDA) at 28 April, 2017. It is a milestone event in the research and applications of plant bioreactor, which ...
Posted by Site editor
|
2017-05-22
LearnMore
Healthgen Biotech's tenth anniversary celebration
In 18th Dec 2016, the innovative high-tech enterprise- Wuhan Healthgen Biotechnology Corp.(Healthgen Biotech, Securities Code: 833101) which is focusing on developing, manufacturing and marketing a serious of recombinant proteins and small peptide products in the rice g...
Posted by Site editor
|
2016-12-24
LearnMore
Pre
1
2
3
4
5
6
Next
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3
Tel
Tel:027-59403931 Ext 8015
BBS